Trillium Asset Management LLC Decreases Position in DENTSPLY SIRONA Inc. (XRAY)
Trillium Asset Management LLC reduced its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 16.6% during the second quarter, Holdings Channel reports. The firm owned 90,613 shares of the medical instruments supplier’s stock after selling 17,982 shares during the period. Trillium Asset Management LLC’s holdings in DENTSPLY SIRONA were worth $5,875,000 as of its most recent filing with the SEC.
A number of other hedge funds have also added to or reduced their stakes in the stock. Ropes Wealth Advisors LLC increased its stake in DENTSPLY SIRONA by 0.3% in the first quarter. Ropes Wealth Advisors LLC now owns 9,003 shares of the medical instruments supplier’s stock valued at $562,000 after buying an additional 29 shares during the period. Wetherby Asset Management Inc. increased its stake in DENTSPLY SIRONA by 0.6% in the second quarter. Wetherby Asset Management Inc. now owns 5,004 shares of the medical instruments supplier’s stock valued at $324,000 after buying an additional 30 shares during the period. HighTower Advisors LLC increased its stake in DENTSPLY SIRONA by 0.6% in the first quarter. HighTower Advisors LLC now owns 6,823 shares of the medical instruments supplier’s stock valued at $424,000 after buying an additional 39 shares during the period. Atria Investments LLC increased its stake in DENTSPLY SIRONA by 1.5% in the second quarter. Atria Investments LLC now owns 4,541 shares of the medical instruments supplier’s stock valued at $294,000 after buying an additional 68 shares during the period. Finally, Creative Planning increased its stake in DENTSPLY SIRONA by 1.0% in the first quarter. Creative Planning now owns 6,800 shares of the medical instruments supplier’s stock valued at $425,000 after buying an additional 70 shares during the period. Hedge funds and other institutional investors own 95.13% of the company’s stock.
DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 54.29 on Tuesday. The firm’s market capitalization is $12.46 billion. The stock’s 50 day moving average is $62.64 and its 200-day moving average is $62.36. DENTSPLY SIRONA Inc. has a 1-year low of $54.04 and a 1-year high of $65.68.
DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.65. The company had revenue of $992.70 million for the quarter, compared to analysts’ expectations of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The firm’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same period last year, the business posted $0.76 earnings per share. Equities research analysts forecast that DENTSPLY SIRONA Inc. will post $2.72 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be paid a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s payout ratio is -10.09%.
COPYRIGHT VIOLATION NOTICE: “Trillium Asset Management LLC Decreases Position in DENTSPLY SIRONA Inc. (XRAY)” was first published by Watch List News and is owned by of Watch List News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US and international copyright law. The legal version of this news story can be accessed at https://www.watchlistnews.com/trillium-asset-management-llc-decreases-position-in-dentsply-sirona-inc-xray/1490297.html.
Several research firms recently commented on XRAY. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Monday. HC Wainwright reissued a “buy” rating and issued a $68.00 price objective (down from $74.00) on shares of DENTSPLY SIRONA in a research note on Monday. TheStreet cut shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research note on Wednesday, August 9th. Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. Finally, Morgan Stanley boosted their price objective on shares of DENTSPLY SIRONA from $66.00 to $67.00 and gave the company an “overweight” rating in a research note on Thursday, August 10th. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the company’s stock. DENTSPLY SIRONA has an average rating of “Hold” and a consensus target price of $66.25.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.